Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × napabucasin × Clear all

Sponsor

Conditions

Neoplasms 4 Neoplasms by Site 3 Colorectal Neoplasms 3 Neoplasms, Glandular and Epithelial 2 Neoplasms by Histologic Type 2 Digestive System Neoplasms 2 Digestive System Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Thymus Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Respiratory Tract Neoplasms 1 Rectal Diseases 1 Pancreatic Neoplasms 1 Pancreatic Diseases 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Endocrine System Diseases 1 Endocrine Gland Neoplasms 1 Colonic Diseases 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Hepatocellular 1 Bronchial Neoplasms 1 Advanced Gastrointestinal Cancer 1

Interventions

Cyclophosphamide 31 fludarabine 23 fludarabine phosphate 22 Tacrolimus 22 Whole-Body Irradiation 21 Mycophenolic Acid 19 Busulfan 14 Melphalan 11 thymoglobulin 10 Methotrexate 10 Granulocyte Colony-Stimulating Factor 10 Antilymphocyte Serum 10 Stem Cell Transplantation 9 Rituximab 9 Filgrastim 8 Thiotepa 7 Cyclosporine 7 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Cytarabine 6 Nivolumab 5 Bortezomib 5 Alemtuzumab 5 trametinib 4 Sirolimus 4 Hematopoietic Stem Cell Transplantation 4 Dexamethasone 4 Cyclosporins 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡